Cart
sales@molnova.com
Rapastinel
CAS No. 117928-94-6
Rapastinel( GLYX-13 | Thr-Pro-Pro-Thr-NH2 )
Catalog No. M10606 CAS No. 117928-94-6
A tetrapeptide (TPPT-amide) that acts as a NMDA receptor glycine site partial agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 74 | In Stock |
|
| 10MG | 105 | In Stock |
|
| 25MG | 219 | In Stock |
|
| 50MG | 323 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRapastinel
-
NoteResearch use only, not for human use.
-
Brief DescriptionA tetrapeptide (TPPT-amide) that acts as a NMDA receptor glycine site partial agonist.
-
DescriptionA tetrapeptide (TPPT-amide) that acts as a NMDA receptor glycine site partial agonist; readily crosses the blood-brain barrier and modulates the NMDA receptor, shows potent cognitive-enhancing properties in a valid in vivo model of learning.Depression Phase 3 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsGLYX-13 | Thr-Pro-Pro-Thr-NH2
-
PathwayMembrane Transporter/Ion Channel
-
TargetiGluR
-
RecptorOthers
-
Research AreaNeurological Disease
-
IndicationDepression
Chemical Information
-
CAS Number117928-94-6
-
Formula Weight413.4686
-
Molecular FormulaC18H31N5O6
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 32 mg/mL
-
SMILESC[C@@H](O)[C@@H](C(N)=O)NC([C@H]1N(C([C@H]2N(C([C@H]([C@H](O)C)N)=O)CCC2)=O)CCC1)=O
-
Chemical NameL-Threoninamide, L-threonyl-L-prolyl-L-prolyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Moskal JR, et al. Neuropharmacology. 2005 Dec;49(7):1077-87.
2. Zhang XL, et al. Neuropharmacology. 2008 Dec;55(7):1238-50.
3. Burgdorf J, et al. Neurobiol Aging. 2011 Apr;32(4):698-706.
molnova catalog
related products
-
Traxoprodil
A potent and NR2B-selective NMDA receptor antagonist; potently protects cultured hippocampal neurons from glutamate toxicity (IC50=10 nM).
-
Rislenemdaz mesylate
Rislenemdaz (MK 0657;CERC 301) is a potent, orally bioavailable, brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.
-
JNJ-61432059
JNJ-61432059 is an oral active and selective negative modulator of TARP γ?8 Selective AMPAR(pIC50: 9.7).
